Literature DB >> 3567548

Linguistic abilities in patients with prefrontal damage.

O P Novoa, A Ardila.   

Abstract

The language abilities of 21 patients with prefrontal lesions (11 right and 10 left) and 15 matched normal subjects were analyzed, using a linguistic ability test designed to evaluate performance in six areas: automatic language, language production, verbal memory, syntax, derivative words, and comprehension of logical grammatical structures. Significant differences in the obtained scores of all groups were found. In spite of formal conservation of language in patients with frontal damage, their complex and conceptual verbal abilities were severely compromised.

Entities:  

Mesh:

Year:  1987        PMID: 3567548     DOI: 10.1016/0093-934x(87)90099-x

Source DB:  PubMed          Journal:  Brain Lang        ISSN: 0093-934X            Impact factor:   2.381


  5 in total

Review 1.  Spanish applications of Luria's assessment methods.

Authors:  A Ardila
Journal:  Neuropsychol Rev       Date:  1999-06       Impact factor: 7.444

2.  Communication in conversation in stroke patients.

Authors:  Marc Rousseaux; Walter Daveluy; Odile Kozlowski
Journal:  J Neurol       Date:  2010-02-09       Impact factor: 4.849

3.  Negative schizophrenic symptoms and the frontal lobe syndrome: one and the same?

Authors:  H Ziauddeen; C Dibben; C Kipps; J R Hodges; P J McKenna
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-08-15       Impact factor: 5.270

4.  A componential analysis of proverb interpretation in patients with frontal lobe epilepsy and temporal lobe epilepsy: relationships with disease-related factors.

Authors:  Carrie R McDonald; Dean C Delis; Joel H Kramer; Evelyn S Tecoma; Vicente J Iragui
Journal:  Clin Neuropsychol       Date:  2007-06-26       Impact factor: 3.535

5.  Manic behavior and asymmetric right frontotemporal dementia from a novel progranulin mutation.

Authors:  Mario F Mendez
Journal:  Neuropsychiatr Dis Treat       Date:  2018-02-26       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.